Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.
J Eur Acad Dermatol Venereol
; 33(10): e348-e350, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31002424
Full text:
1
Database:
MEDLINE
Main subject:
Sarcoidosis
/
MAP Kinase Kinase Kinases
/
Erdheim-Chester Disease
/
Proto-Oncogene Proteins B-raf
/
Extracellular Signal-Regulated MAP Kinases
/
Protein Kinase Inhibitors
Type of study:
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2019
Type:
Article